Media Coverage

An ISB study found that pregnant patients with lupus or antiphospholipid syndrome have a higher risk for preterm birth, although autoimmune diseases in general are “only weakly associated” with adverse pregnancy outcomes.

ISB researchers offer promising avenues for exploring multi-disease therapeutic strategies.

The association between immune-mediated inflammatory diseases (IMIDs) and adverse pregnancy outcomes varies with the nature of IMID and the presence of comorbidities.

ISB Associate Professor Dr. Jennifer Hadlock discussed her recent paper showing that comorbidities play a major role in poor birth outcomes, such as preterm birth and low birth weight, in patients with specific autoimmune diseases.

An ISB-led research project examining autoimmune disease and pregnancy was cited as an example of encouraging critical thinking.

ISB President Dr. Jim Heath talked with Science in Seattle in a wide-ranging interview that touched on his paper in Cell Reports showing how T-cell receptors form, his transition from chemistry to biology, challenges facing life scientists, and more.

As AI and new imaging tools give researchers vast amounts of data on tumors, they are winning some battles against cancer. ISB President Dr. Jim Heath was interviewed for this extensively reported feature story for Newsweek Magazine.

ISB Associate Professor Dr. Sean Gibbons spoke with Mark O. Martin from the University of Puget Sound. Gibbons talked about how the study of host-associated microbial communities gives us insights into evolution, ecology and human health.